Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chagas' heart disease.

A Rassi1, A Rassi, W C Little

  • 1Section of Cardiology, Anis Rassi Hospital, Goiânia, Goias, Brazil.

Clinical Cardiology
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Chagas' disease, caused by Trypanosoma cruzi, affects millions in Latin America. Early diagnosis and treatment with benznidazole, alongside cardiac management, are crucial for improving patient outcomes and preventing transmission.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantibodies to neurotrophic receptors TrkA, TrkB and TrkC in patients with acute Chagas' disease.

Scandinavian journal of immunology·2010
Same author

Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.

Heart (British Cardiac Society)·2009
Same author

Isolated renal haemangioma in children: presentation and management.

BJU international·2002
Same author

Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi.

Parasitology research·2002
Same author

Hypertensive pulmonary oedema is due to diastolic dysfunction.

European heart journal·2001
Same author

Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance.

Journal of the American College of Cardiology·2001

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Parasitology

Background:

  • Chagas' disease is a significant public health concern in Latin America, caused by the protozoan parasite Trypanosoma cruzi.
  • Transmission occurs via infected insect vectors or nonvectorial routes like blood transfusions.
  • Chronic infection often leads to severe cardiac complications decades after initial exposure.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and management of Chagas' disease, with a focus on cardiac involvement.
  • To highlight the challenges posed by migration and potential transmission in non-endemic regions.
  • To discuss current and potential therapeutic strategies for Chagas' heart disease.

Main Methods:

  • Review of existing literature on Chagas' disease epidemiology, clinical presentation, and treatment.

Related Experiment Videos

  • Analysis of diagnostic criteria, including serologic tests and clinical manifestations.
  • Evaluation of therapeutic options for both acute and chronic phases of the infection.

    • Main Results:

    • Chagas' heart disease can manifest as arrhythmias, heart failure, and sudden death.
    • An estimated 16–18 million individuals are infected in Latin America.
    • Misdiagnosis in immigrant populations and transfusion-related transmission are critical concerns.

    Conclusions:

    • Early diagnosis and treatment with benznidazole are effective for initial infections and may benefit chronic cases.
    • Management of cardiac involvement using medications like amiodarone, ACE inhibitors, and pacemakers can improve survival.
    • Increased awareness and diagnostic efforts are essential to address Chagas' disease in non-endemic countries.